Bessemer Group Inc Bluebird Bio, Inc. Transaction History

Bessemer Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	BUY	$34.44 - $43.75 $2.5 Million - $3.18 Million	72,673 Added 22.3%	398,494 $21.5 Million
Q4 2019 Feb 04, 2020	BUY	$46.96 - $61.67 $2.09 Million - $2.75 Million	44,601 Added 15.86%	325,821 $28.6 Million
Q3 2019 Nov 07, 2019	BUY	$59.47 - $93.1 $8.2 Million - $12.8 Million	137,929 Added 96.26%	281,220 $25.8 Million
Q2 2019 Jul 19, 2019	BUY	$75.84 - $105.21 $10.9 Million - $15.1 Million	143,261 Added 477536.66%	143,291 $18.2 Million
Q1 2019 May 13, 2019	BUY	$64.44 - $104.11 $1,933 - $3,123	30 New	30 $5,000

128

62.8M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $598M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

Stay updated on Bessemer Group Inc with notifications on news.